Health technology company Carevive—which developed a platform that helps clinicians create personalized treatment plans for cancer patients—won a new major backer last month.
The company banked a series C equity investment of $18 million with support from Philips Health Technology Ventures. Phillips joined prior investors HLM Venture Partners, LRVHealth, Cerner and founder Madelyn Trupkin Herzfeld in the round.
Carevive’s platform allows clinicians to tailor cancer care management programs for each patient’s needs, informed by real-world patient experiences and outcomes, not just clinical data. Its remote symptom management system means patients need to take fewer trips to health centers. And Carevive’s data and analytics are helping researchers design innovative cancer care delivery models, payers to reimburse treatments effectively and life science companies to develop personalized therapies for cancer.
Carevive plans to use the funds to bring its software and analytics platform, which uniquely connects clinical data with patients’ real-world reported experiences, to even more clinicians, patients, life science companies, and payers,” said Bruno Lempernesse, Carevive’s CEO.
Here’s a snapshot of other health IT funding deals of note in February:
Virtual care expansion: Online medical appointment booking company Zocdoc banked $150 million in new growth financing led by Francisco Partners.
Big data: Innovaccer joined the ranks of digital health unicorns when it secured $105 million in a series D funding round, bringing its valuation to $1.3 billion. The round was led by Tiger Global Management and existing investors Steadview Capital, Dragoneer, B Capital Group, Mubadala Capital and M12 (Microsoft’s venture fund), which participated in the round, as well as new investor OMERS Growth Equity.
Cancer genomics company: Personal Genome Diagnostics has raised $103 million in series C funding led by Cowen Healthcare Investments. Other investors in the round include Northpond Ventures, Vensana Capital, Rock Springs Capital, Kern Capital, Sands Capital, PFM Health Sciences, Windham Ventures, New Enterprise Associates, Innovatus Capital Partners and Catalio Capital Management.
ER infrastructure: RapidSOS, a company that built a platform to make it easier for first response teams to do their jobs, just banked $85 million to scale its technology. The company’s series C funding round was led by global venture capital and private equity firm Insight Partners. The investment brings RapidSOS’ total funding to $200 million.
Behavioral health: Modern Health has closed a $74 million series D investment round. The investment round was led by Founders Fund. Lachy Groom also invested in the round. The infusion…